Industry News
Pharmaceutical Industry News
Viatris inks $264M deal to resolve long-running EpiPen pay-for-delay case
Viatris inks $264M deal to resolve long-running EpiPen pay-for-delay case kdunleavy Mon, 02/28/2022 - 09:10
After raking in billions with its COVID shot, Moderna faces patent infringement suit related to vaccine delivery tech
After raking in billions with its COVID shot, Moderna faces patent infringement suit related to vaccine delivery tech fkansteiner Mon, 02/28/2022 - 09:03
Viatris unloads biosimilar business to partner Biocon for $3.3B
Viatris unloads biosimilar business to partner Biocon for $3.3B aliu Mon, 02/28/2022 - 05:19
‘Light up for Rare’ spotlights rare disease to help break the isolation COVID has wrought
'Light up for Rare' spotlights rare disease to help break the isolation COVID has wrought badams Mon, 02/28/2022 - 04:15
AstraZeneca doubles down on animation—with a ’60s spin this time—in new Breztri ad campaign
AstraZeneca doubles down on animation—with a '60s spin this time—in new Breztri ad campaign badams Sat, 02/26/2022 - 07:57
Judge backs Johnson & Johnson in bankruptcy ploy for talc litigation, clears way for settlement
Judge backs Johnson & Johnson in bankruptcy ploy for talc litigation, clears way for settlement kdunleavy Fri, 02/25/2022 - 16:07
EMA expands nods for BMS, Eli Lilly, Novartis drugs and backs Biohaven, VBI, Myovant therapies for first time
EMA expands nods for BMS, Eli Lilly, Novartis drugs and backs Biohaven, VBI, Myovant therapies for first time aliu Fri, 02/25/2022 - 11:36
Emergent underway with $100M in manufacturing upgrades as it gears up for ‘post-pandemic work’
Emergent underway with $100M in manufacturing upgrades as it gears up for 'post-pandemic work' kdunleavy Fri, 02/25/2022 - 10:15
Johnson & Johnson, distributor giants finalize $26B opioid settlement as states pile into landmark deal
Johnson & Johnson, distributor giants finalize $26B opioid settlement as states pile into landmark deal aliu Fri, 02/25/2022 - 09:45
Editor’s Corner: Fierce Pharma gets a fierce makeover
Editor's Corner: Fierce Pharma gets a fierce makeover esagonowsky Fri, 02/25/2022 - 09:38
Companies Finalize $26 Billion Deal With States and Cities to End Opioid Lawsuits
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be used for addiction treatment and prevention.
Fierce Pharma Asia—Enhertu’s HER2-low breast cancer win; Takeda’s $2B gene therapy pact; Xtandi march-in campaign
Fierce Pharma Asia—Enhertu's HER2-low breast cancer win; Takeda's $2B gene therapy pact; Xtandi march-in campaign aliu Fri, 02/25/2022 - 06:53
Horizon joins with internet sensation to bring lyrical awareness to rare diseases
Horizon joins with internet sensation to bring lyrical awareness to rare diseases sharon.coey Fri, 02/25/2022 - 06:36
Eli Lilly, Boehringer Ingelheim’s Jardiance clinches heart failure edge with FDA nod for wider label
Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label fkansteiner Thu, 02/24/2022 - 14:11
Teva, Endo and more back on the hook in San Francisco opioid trial
Teva, Endo and more back on the hook in San Francisco opioid trial fkansteiner Thu, 02/24/2022 - 11:23
Merck KGaA pledges $550M in manufacturing upgrades after closing buyout of mRNA CDMO Exelead
Merck KGaA pledges $550M in manufacturing upgrades after closing buyout of mRNA CDMO Exelead kdunleavy Thu, 02/24/2022 - 11:20
GlaxoSmithKline, Medicago’s plant-based COVID vaccine, Covifenz, wins first approval
GlaxoSmithKline, Medicago’s plant-based COVID vaccine, Covifenz, wins first approval aliu Thu, 02/24/2022 - 11:17
BioMarin eyes first profits in 2022 as dwarfism drug launch kicks into gear, hemophilia gene therapy refiling nears
BioMarin eyes first profits in 2022 as dwarfism drug launch kicks into gear, hemophilia gene therapy refiling nears aliu Thu, 02/24/2022 - 10:12
FDA will limit the use of GlaxoSmithKline and Vir’s COVID-19 antibody treatment in some geographic areas
FDA will limit the use of GlaxoSmithKline and Vir's COVID-19 antibody treatment in some geographic areas kdunleavy Thu, 02/24/2022 - 09:54
WHO expands mRNA tech transfer to more countries in battle against COVID
WHO expands mRNA tech transfer to more countries in battle against COVID jkeenan Thu, 02/24/2022 - 08:59